January 30, 2019
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Read More
January 30, 2019
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
Read More
January 30, 2019
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Nintedanib(BIBF1120) in Thyroid Cancer
Read More
January 30, 2019
Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
Read More
January 30, 2019
Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer
Read More
January 30, 2019
Cabozantinib-s-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Read More
January 30, 2019
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Read More
January 30, 2019
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Read More
January 30, 2019
A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
Read More
Load More
X